title: Economics and ethics of paediatric respiratory extra corporeal life support.
abstract: Extra corporeal membrane oxygenation (ECMO) is a form of life support, which facilitates gas exchange outside the body via an oxygenator and a centrifugal pumping system. A paediatric cardiac ECMO programme was established in 2005 at Our Lady's Children's Hospital, Crumlin (OLCHC) and to date 75 patients have received ECMO, the majority being post operative cardiac patients. The outcome data compares favourably with international figures. ECMO has been most successful in the treatment of newborn infants with life threatening respiratory failure from conditions such as meconium aspiration, respiratory distress syndrome and respiratory infections. There is no formal paediatric respiratory ECMO programme at OLCHC, or anywhere else in Ireland. Currently, neonates requiring respiratory ECMO are transferred to centres in Sweden or the UK at an average cost of 133,000 Euros/infant, funded by the Health Service Executive E112 treatment abroad scheme. There is considerable morbidity associated with the transfer of critically ill infants, as well as significant psycho-social impact on families. OLCHC is not funded to provide respiratory ECMO, although the equipment and expertise required are similar to cardiac ECMO and are currently in place. The average cost of an ECMO run at OLCHC is 65,000 Euros. There is now a strong argument for a fully funded single national cardiac and respiratory paediatric ECMO centre, similar to that for adult patients.
authors.affiliation: Our Lady's Children's Hospital, Crumlin, Dublin 12. michaelcallaghan7@hotmail.com
authors.forename: M
authors.initials: M
authors.lastname: Callaghan
authors.forename: Y
authors.initials: Y
authors.lastname: Doyle
authors.forename: B
authors.initials: B
authors.lastname: O'Hare
authors.forename: M
authors.initials: M
authors.lastname: Healy
authors.forename: L
authors.initials: L
authors.lastname: Nölke
mesh_terms: D015199:Extracorporeal Membrane Oxygenation / Q000191:economics* / Q000941:ethics* / Q000295:instrumentation / Q000379:methods; D005260:Female; D006548:Hernia, Diaphragmatic / Q000150:complications / Q000175:diagnosis / Q000191:economics / Q000628:therapy; D065630:Hernias, Diaphragmatic, Congenital; D006776:Hospitals, Pediatric / Q000191:economics / Q000941:ethics; D006801:Humans; D007223:Infant; D007494:Ireland; D008297:Male; D057193:Medical Tourism / Q000191:economics / Q000941:ethics; D012127:Respiratory Distress Syndrome, Newborn / Q000175:diagnosis / Q000191:economics* / Q000209:etiology / Q000628:therapy; D012131:Respiratory Insufficiency / Q000175:diagnosis / Q000191:economics* / Q000209:etiology / Q000628:therapy; D013548:Sweden; D016896:Treatment Outcome